Principal Financial Group Inc. Has $12.83 Million Position in Amedisys Inc (NASDAQ:AMED)

Principal Financial Group Inc. reduced its position in Amedisys Inc (NASDAQ:AMED) by 1.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 229,259 shares of the health services provider’s stock after selling 2,429 shares during the period. Principal Financial Group Inc. owned about 0.68% of Amedisys worth $12,829,000 as of its most recent filing with the SEC.

A number of other large investors have also recently modified their holdings of AMED. Federated Investors Inc. PA increased its stake in Amedisys by 2.3% in the second quarter. Federated Investors Inc. PA now owns 1,929 shares of the health services provider’s stock valued at $122,000 after acquiring an additional 44 shares during the last quarter. State Board of Administration of Florida Retirement System boosted its position in Amedisys by 0.5% in the second quarter. State Board of Administration of Florida Retirement System now owns 19,658 shares of the health services provider’s stock valued at $1,235,000 after buying an additional 93 shares in the last quarter. Municipal Employees Retirement System of Michigan boosted its position in Amedisys by 3.5% in the second quarter. Municipal Employees Retirement System of Michigan now owns 6,590 shares of the health services provider’s stock valued at $414,000 after buying an additional 220 shares in the last quarter. Suntrust Banks Inc. boosted its position in Amedisys by 4.3% in the second quarter. Suntrust Banks Inc. now owns 5,702 shares of the health services provider’s stock valued at $358,000 after buying an additional 237 shares in the last quarter. Finally, Texas Permanent School Fund boosted its position in Amedisys by 1.2% in the second quarter. Texas Permanent School Fund now owns 20,439 shares of the health services provider’s stock valued at $1,284,000 after buying an additional 243 shares in the last quarter. Institutional investors and hedge funds own 94.47% of the company’s stock.

Shares of Amedisys Inc (NASDAQ AMED) traded up $0.93 during mid-day trading on Friday, reaching $55.31. 1,040,000 shares of the company’s stock were exchanged, compared to its average volume of 498,679. Amedisys Inc has a twelve month low of $41.98 and a twelve month high of $65.91. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.16. The company has a market cap of $1,910.00, a P/E ratio of 26.02, a price-to-earnings-growth ratio of 1.32 and a beta of 0.70.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings data on Tuesday, November 7th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.54 by $0.02. The business had revenue of $380.20 million during the quarter, compared to the consensus estimate of $384.59 million. Amedisys had a net margin of 2.88% and a return on equity of 14.68%. The firm’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.36 EPS. research analysts predict that Amedisys Inc will post 2.23 earnings per share for the current fiscal year.

AMED has been the topic of a number of research analyst reports. Oppenheimer restated a “buy” rating and issued a $60.00 target price on shares of Amedisys in a research report on Friday, September 15th. Jefferies Group reiterated a “buy” rating and set a $60.00 price target on shares of Amedisys in a report on Thursday, October 12th. SunTrust Banks restated a “buy” rating and issued a $60.00 target price on shares of Amedisys in a report on Monday, October 9th. Mizuho restated a “buy” rating and issued a $65.00 target price (up previously from $55.00) on shares of Amedisys in a report on Wednesday, November 8th. Finally, Benchmark upgraded shares of Amedisys from a “hold” rating to a “buy” rating and set a $56.00 target price on the stock in a report on Thursday, November 2nd. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $61.00.

COPYRIGHT VIOLATION NOTICE: This news story was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://www.dispatchtribunal.com/2017/12/16/principal-financial-group-inc-has-12-83-million-stake-in-amedisys-inc-amed.html.

About Amedisys

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply